Millions of women across England who have fallen behind with their cervical screening are being offered a new way to get checked—without having to attend an appointment. From 25 August, the National Health Service (NHS) began rolling out free home high-risk human papillomavirus (HPV) testing kits to nearly four million women who have previously missed cervical screening invitations.
The move could make screening much easier for women who find traditional appointments difficult, uncomfortable or simply hard to fit into a busy schedule. Instead of having a clinician take the sample, eligible women can collect a vaginal sample themselves at home and send it to an NHS laboratory to check for HPV, which can cause cervical cancer.
Who Can Get the Free NHS Kit?
The home-testing service is being introduced gradually. The first group being invited is women aged 30 to 65 in England who have not attended cervical screening after previous NHS invitations.
It is also important to know that the home test is invitation-only. If you are eligible, the NHS may contact you through the NHS App, text message, email or a letter. Once invited, you can order your free kit through the NHS App or your NHS online account.
How Does the Home Test Work?
The kit contains a swab, similar to a long cotton bud, which is used to collect a sample from inside the vagina. Once the sample has been collected following the instructions, it is posted back to the NHS for testing, with the return provided free of charge.
The test looks for high-risk types of HPV. A positive result does not immediately mean you have cervical cancer. Instead, it means you will need further assessment.
If high-risk HPV is found, you will be invited to attend a follow-up cervical screening appointment. A healthcare professional can then take a sample directly from the cervix and check for abnormal cell changes that could potentially develop into cancer.
NHS Pushes To Eliminate Cervical Cancer by 2040
According to NHS, only 68.8% of eligible women in England are currently up to date with cervical screening—below the department's target of 80%. That leaves around four million women behind with their routine screening.
Some women may struggle to attend screening because of practical commitments, while others may feel anxious or uncomfortable about being examined in person. Offering a self-testing option gives those who have repeatedly missed appointments another route into screening.
The programme follows the YouScreen trial in North London, which found that HPV self-sampling could increase participation in cervical screening and help reach under-screened women, including those from underserved groups. NHS England is also working towards its goal of eliminating cervical cancer as a public health problem in England by 2040.
The Global Impact of Cervical Cancer
Cervical cancer remains a major health concern worldwide. In 2022, around 660,000 women were diagnosed with cervical cancer globally, while approximately 350,000 died from the disease, according to the World Health Organisation (WHO).
Yet cervical cancer is also one of the most preventable and treatable cancers. Regular screening can identify high-risk HPV or early cell changes before they develop into cancer, while cases diagnosed at an early stage can often be treated successfully. This is why making screening easier matters.
Whether it is through an NHS appointment or a convenient home HPV test, taking that first step could help detect potential problems earlier and ensure women receive the follow-up care they need.
